Literature DB >> 10076568

Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells.

S Kitamura1, Y Miyazaki, Y Shinomura, S Kondo, S Kanayama, Y Matsuzawa.   

Abstract

Peroxisome proliferator-activated receptor gamma (PPAR gamma), one of the nuclear receptors expressed in adipose tissue, plays an important role in adipocyte differentiation. In this study, we investigated the expression of PPAR gamma and its role in cellular growth and differentiation in six colon cancer cell lines: HT-29, CaCo-2, SW-480, DLD-1, LoVo, and T-84. All six expressed PPAR gamma mRNA and protein, shown respectively on northern and western blot analyses. Luciferase assay in HT-29 cells, which strongly express PPAR gamma, showed that troglitazone, a selective ligand for PPAR gamma, transactivated the transcription of a peroxisome proliferator response element (PPRE)-driven promoter. Furthermore, troglitazone caused a marked decrease in [3H]thymidine incorporation and G1 cell-cycle arrest determined by flow cytometry. Finally, troglitazone induced expression of mRNAs for villin and intestinal alkaline phosphatase, markers for enterocyte differentiation. In conclusion, human colon cancer cells express PPAR gamma, the ligands of which inhibit cell growth and induce differentiation markers.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10076568      PMCID: PMC5925976          DOI: 10.1111/j.1349-7006.1999.tb00668.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  19 in total

1.  Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa.

Authors:  A Mansén; H Guardiola-Diaz; J Rafter; C Branting; J A Gustafsson
Journal:  Biochem Biophys Res Commun       Date:  1996-05-24       Impact factor: 3.575

2.  Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.

Authors:  G Krey; O Braissant; F L'Horset; E Kalkhoven; M Perroud; M G Parker; W Wahli
Journal:  Mol Endocrinol       Date:  1997-06

3.  The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers.

Authors:  R N DuBois; R Gupta; J Brockman; B S Reddy; S L Krakow; M A Lazar
Journal:  Carcinogenesis       Date:  1998-01       Impact factor: 4.944

4.  Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists.

Authors:  R Mukherjee; L Jow; G E Croston; J R Paterniti
Journal:  J Biol Chem       Date:  1997-03-21       Impact factor: 5.157

5.  Identification of an extended half-site motif required for the function of peroxisome proliferator-activated receptor alpha.

Authors:  S Osada; T Tsukamoto; M Takiguchi; M Mori; T Osumi
Journal:  Genes Cells       Date:  1997-05       Impact factor: 1.891

6.  Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

Authors:  P Tontonoz; S Singer; B M Forman; P Sarraf; J A Fletcher; C D Fletcher; R P Brun; E Mueller; S Altiok; H Oppenheim; R M Evans; B M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

7.  A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.

Authors:  S A Kliewer; J M Lenhard; T M Willson; I Patel; D C Morris; J M Lehmann
Journal:  Cell       Date:  1995-12-01       Impact factor: 41.582

8.  15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.

Authors:  B M Forman; P Tontonoz; J Chen; R P Brun; B M Spiegelman; R M Evans
Journal:  Cell       Date:  1995-12-01       Impact factor: 41.582

9.  Terminal differentiation of human breast cancer through PPAR gamma.

Authors:  E Mueller; P Sarraf; P Tontonoz; R M Evans; K J Martin; M Zhang; C Fletcher; S Singer; B M Spiegelman
Journal:  Mol Cell       Date:  1998-02       Impact factor: 17.970

10.  Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor.

Authors:  P Tontonoz; E Hu; B M Spiegelman
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582

View more
  66 in total

1.  Enteric glia modulate epithelial cell proliferation and differentiation through 15-deoxy-12,14-prostaglandin J2.

Authors:  Kalyane Bach-Ngohou; Maxime M Mahé; Philippe Aubert; Hind Abdo; Sébastien Boni; Arnaud Bourreille; Marc G Denis; Bernard Lardeux; Michel Neunlist; Damien Masson
Journal:  J Physiol       Date:  2010-05-17       Impact factor: 5.182

2.  Molecular basis of differentiation therapy for soft tissue sarcomas.

Authors:  Gaurav Luther; Richard Rames; Eric R Wagner; Gaohui Zhu; Qing Luo; Yang Bi; Stephanie H Kim; Jian-Li Gao; Enyi Huang; Ke Yang; Linyuan Wang; Xing Liu; Mi Li; Ning Hu; Yuxi Su; Xiaoji Luo; Liang Chen; Jinyong Luo; Rex C Haydon; Hue H Luu; Lan Zhou; Tong-Chuan He
Journal:  Trends Cancer Res       Date:  2010

3.  Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways.

Authors:  Kiyoshi Yamaguchi; Maria Cekanova; Michael F McEntee; Joo-Heon Yoon; Susan M Fischer; Ingrid B Renes; Isabelle Van Seuningen; Seung Joon Baek
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

Review 4.  Pax-8-PPAR-γ fusion protein in thyroid carcinoma.

Authors:  Priyadarshini Raman; Ronald J Koenig
Journal:  Nat Rev Endocrinol       Date:  2014-07-29       Impact factor: 43.330

5.  Thiazolidinediones as anti-cancer agents.

Authors:  Carmelo Blanquicett; Jesse Roman; C Michael Hart
Journal:  Cancer Ther       Date:  2008

6.  Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas.

Authors:  Chuanbing Zang; Marlies Wächter; Hongyu Liu; Maximilian G Posch; Martin H Fenner; Christine Stadelmann; Andreas von Deimling; Kurt Possinger; Keith L Black; H Phillip Koeffler; Elena Elstner
Journal:  J Neurooncol       Date:  2003-11       Impact factor: 4.130

7.  Peroxisome proliferator-activated receptor-gamma activated by ligands can inhibit human lung cancer cell growth through induction of apoptosis.

Authors:  Min Zhang; Ping Zou; Ming Bai; Yang Jin; Xiaonan Tao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

8.  Peroxisome proliferator-activated receptor-γ agonist-mediated inhibition of cell growth is independent of apoptosis in human epidermoid carcinoma A431 cells.

Authors:  Qian Li; Yu-Sheng Peng; Ping-Jiao Chen; Meng-Lei Wang; Can Cao; Hao Xiong; Jing Zhang; Ming-Hua Chen; Xue-Biao Peng; Kang Zeng
Journal:  Oncol Lett       Date:  2018-02-28       Impact factor: 2.967

9.  Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells.

Authors:  Chan Woo Cheon; Dae Hwan Kim; Dong Heon Kim; Yong Hoon Cho; Jae Hun Kim
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

Review 10.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.